Tomomi Yasue

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery et al. · Neurology · 2016 · 217 citations · Full text

Medicine, Rehabilitation Medicine, Geriatric Rehabilitation +14

Phase2 study of bevacizumab with carboplatin–paclitaxel for non-small cell lung cancer with malignant pleural effusion

Motohiro Tamiya, Akihiro Tamiya, Tadahiro Yamadori et al. · Medical Oncology · 2013 · 47 citations

Medicine, Oncology, Pharmacology +15

Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.

Motohiro Tamiya, Akihiro Tamiya, Tomomi Yasue et al. · PubMed · 2016 · 20 citations

Medicine, Oncology, Pharmacology +16

Clinical Significance of the Serum Crosslinked N-Telopeptide of Type I Collagen as a Prognostic Marker for Non–Small-Cell Lung Cancer

Motohiro Tamiya, Masashi Kobayashi, Osamu Morimura et al. · Clinical Lung Cancer · 2012 · 17 citations

Medicine, Oncology, Molecular Oncology +6

Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer

Motohiro Tamiya, Hidekazu Suzuki, Masashi Kobayashi et al. · Medical Oncology · 2011 · 14 citations

Medicine, Cancer Biology, Oncology +13